- Home
- / Vitrolife
Vitrolife
Stock Price
KR243.4
2024-10-29
Market Capitalization
KR33 B
2024-10-29
Revenue
KR3.4 B
FY, 2025
Vitrolife Summary
Company Summary
- Overview
- Vitrolife is a biotechnology company that develops products to counter fertility issues in humans. The Сompany also develops various media that enable researchers and cell therapy companies to use cells for therapeutic purposes.
- Type
- Public
- Status
- Active
- Founded
- 1981
- HQ
- Västra Frölunda, SE | view all locations
- Website
- https://www.vitrolife.com/
- Cybersecurity rating
- ESG rating
Table of Contents
LocationsView all
1 location detected
Västra Frölunda, Västra Götalands län HQ
Sweden
Gustaf Werners gata 2
Vitrolife Financials
Summary Financials
- Revenue (Q1, 2026)
- kr807.0M
- Gross profit (Q1, 2026)
- kr552.0M
- Net income (Q1, 2026)
- kr101.0M
- Cash (Q1, 2026)
- kr886.0M
- EBIT (Q1, 2026)
- kr149.0M
- Enterprise value
- $33.7B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026